美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Surrozen, Inc. Warrant

0.0175

0.0000

成交量：- -

成交額：- -

市值：15.00萬

市盈率：0.00

高：0.0175

開：0.0175

低：0.0175

收：0.0175

52周最高：1.21

52周最低：0.0010

股本：857.04萬

流通股本：857.04萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-19.7558

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Surrozen, Inc. Warrant

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.surrozen.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Surrozen, Inc.是一家註冊於特拉華州並於2020年8月21日成立的生物技術公司，該公司致力於發現和開發候選藥物以選擇性調節Wnt通路。Surrozen正在開發組織特異性抗體，旨在利用人體現有的生物修復機制，潛在應用於多種疾病領域，包括腸道、肝臟、視網膜、角膜、肺、腎臟、耳蝸、皮膚、胰腺和中樞神經系統疾病。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SRZNW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SRZNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRZNW\",,,,,undefined,":{"symbol":"SRZNW","market":"US","secType":"STK","nameCN":"Surrozen, Inc. Warrant","latestPrice":0.0175,"timestamp":1775851200000,"preClose":0.0175,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":8570358,"shares":8570358,"eps":-19.7558,"marketStatus":"盤前交易","change":0,"latestTime":"04-13 04:28:04 EDT","open":0.0175,"high":0.0175,"low":0.0175,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-19.7558,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776087000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0175,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRZNW\",,,,,undefined,":{"symbol":"SRZNW","floatShares":8570358,"roa":"--","roe":"--","lyrEps":0,"shares":8570358,"dividePrice":0,"high":0.0175,"amplitude":0,"preClose":0.0175,"low":0.0175,"week52Low":0.001,"pbRate":"--","week52High":1.21,"institutionHeld":0,"latestPrice":0.0175,"eps":-19.7558,"divideRate":0,"volume":0,"delay":0,"ttmEps":-19.7558,"open":0.0175,"prevYearClose":0.02,"prevWeekClose":0.017,"prevMonthClose":0.016,"prevQuarterClose":0.016,"fiveDayClose":0.017,"twentyDayClose":0.017,"sixtyDayClose":0.0208},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SRZNW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SRZNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SRZNW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.surrozen.com","stockEarnings":[{"period":"1week","weight":0.0294},{"period":"1month","weight":0.0294},{"period":"3month","weight":-0.2045},{"period":"6month","weight":0.2963},{"period":"1year","weight":-0.1667},{"period":"ytd","weight":-0.125}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Surrozen, Inc.是一家註冊於特拉華州並於2020年8月21日成立的生物技術公司，該公司致力於發現和開發候選藥物以選擇性調節Wnt通路。Surrozen正在開發組織特異性抗體，旨在利用人體現有的生物修復機制，潛在應用於多種疾病領域，包括腸道、肝臟、視網膜、角膜、肺、腎臟、耳蝸、皮膚、胰腺和中樞神經系統疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.09883},{"month":2,"riseRate":0.666667,"avgChangeRate":0.247837},{"month":3,"riseRate":0,"avgChangeRate":-0.27231},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.073068},{"month":5,"riseRate":0.6,"avgChangeRate":0.10003},{"month":6,"riseRate":0.6,"avgChangeRate":-0.028116},{"month":7,"riseRate":0.2,"avgChangeRate":-0.108589},{"month":8,"riseRate":0.6,"avgChangeRate":0.098176},{"month":9,"riseRate":0.2,"avgChangeRate":-0.095012},{"month":10,"riseRate":0.6,"avgChangeRate":-0.049469},{"month":11,"riseRate":0.6,"avgChangeRate":0.890028},{"month":12,"riseRate":0.6,"avgChangeRate":-0.064593}],"exchange":"NASDAQ","name":"Surrozen, Inc. Warrant","nameEN":"Surrozen, Inc. Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SRZNW\",market:\"US\",,,undefined,":null}}